Peter Lim

Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I

Kathleen N. Moore, Amit M. Oza, Nicoletta Colombo et al. · Annals of Oncology · 2021 · 292 citations · Full text

Medicine, Oncology, Pharmacology +16

A comparative detail analysis of the learning curve and surgical outcome for robotic hysterectomy with lymphadenectomy versus laparoscopic hysterectomy with lymphadenectomy in treatment of endometrial cancer: A case-matched controlled study of the first one hundred twenty two patients

Peter Lim, E.Y. Kang, Do Hwan Park · Gynecologic Oncology · 2010 · 176 citations

Medicine, Gynecology, Surgery +17

Learning Curve and Surgical Outcome for Robotic-Assisted Hysterectomy with Lymphadenectomy: Case-Matched Controlled Comparison with Laparoscopy and Laparotomy for Treatment of Endometrial Cancer

Peter Lim, E.Y. Kang, Do Hwan Park · Journal of Minimally Invasive Gynecology · 2010 · 130 citations

Medicine, Gynecology, Surgery +15

Multicenter analysis comparing robotic, open, laparoscopic, and vaginal hysterectomies performed by high‐volume surgeons for benign indications

Peter Lim, John T. Crane, Eric J. English et al. · International Journal of Gynecology & Obstetrics · 2016 · 109 citations · Full text

Medicine, Gynecology, Surgery +9

Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer

Lucy Gilbert, Ana Oaknin, Ursula A. Matulonis et al. · Gynecologic Oncology · 2023 · 108 citations

Medicine, Oncology, Pharmacology +17